At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Identification of Urinary Cytokines in Patients With Overactive Bladder (OAB)
In Brief
An observational study for Overactive Bladder and Urinary Tract Infection. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Overactive bladder (OAB) is a widespread condition characterized by urgency, urge incontinence, nocturia and excessive urinary frequency, affecting millions of people worldwide. In two epidemiological studies, OAB was found in about 17% of American and European populations. This accounts for an estimated 33 million patients suffering from OAB in the USA. The disorder constitutes a psychological stress that impacts the patient's social life.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOveractive Bladder, Urinary Tract Infection
CountriesUnited States
CollaboratorsAstellas Pharma US, Inc.
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2007
Primary CompletionSep 2008
First PostedMar 2009
Study CompletionAug 2009
TodayJul 2026
First PostedMar 25, 2009
Enrollment StartMar 1, 2007
Primary CompletionSep 1, 2008
Study CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 17.3 years ago